The Future of AI and Personalized Cancer Care:
How can patient empowerment accelerate improved cancer outcomes?
The Future of AI and Personalized Cancer Care:
How can patient empowerment accelerate improved cancer outcomes?
On June 2, 2023, we were honored to host a pre-ASCO Symposium where we brought together patients, practitioners, and experts in life sciences, digital health, policy, and advocacy to delve into the transformative power of generative AI in the delivery of cancer care.
See highlights from the Symposium below.
Discussion Highlights: Putting Patients First
Discussion Highlights: Creating the Ecosystem for Equitable Patient Empowerment
Partnering with Medicine & Industry
The Patient Voice
Want to see more? You can!
Three important discussions
Panel 1: AI in support of delivering patient-centric, guideline-concordant cancer care
In the age of AI, oncologists now have an opportunity to leverage patient-reported outcomes and real-world data to drive guideline-concordant care. Join us as we explore AI’s role in supporting physician decision-making and its ability to, in turn, better serve patients.
Panel 2: The role of AI in advancing equitable clinical trial recruitment and access
Join us as our panel of experts and patient advocates discusses the role of AI & digital health solutions in equitable clinical trial recruitment and examine how AI-driven patient empowerment and self-advocacy can contribute to clinical-trial matching.
Panel 3: The value of AI-powered, direct-to-patient activation in the consumer privacy era
Explore how opt-in AI can empower patients with personalized, relevant information, and how this approach coupled with true patient ownership of their medical records will both support the pharmaceutical industry’s commercial goals but also better serve patients.
Industry experts & patient advocate speakers
Maya R. Said, ScD
Founder & CEO, Outcomes4Me
Sunil Verma, MD
Senior VP, Global Head of Oncology, Medical, AstraZeneca
Aradhana Ghosh, MD
VP, Oncology Informatics,
Labcorp Oncology
Arun Krishna, PhD
VP, Head of US Lung Cancer Business, AstraZeneca
Crystal S. Denlinger, MD, FACP
Senior VP, Chief Scientific Officer, NCCN©
V.K. Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Kimberly Richardson
Founder, Black Cancer Collaborative, Breast & Ovarian Cancer Survivor
Prasanth Reddy, MD, MPH, FACP
Senior VP & Global Head of Enterprise Oncology, Labcorp
Debra Friedman, MD, MS
Director, Pediatric Hematology & Oncology, Vanderbilt-Ingram Cancer Center
Steven Isakoff, MD, PhD
Associate Director, Clinical Research, Mass General Cancer Center
Chadi Nabhan, MD, MBA, FACP
Senior VP & Chairman, Caris Precision Oncology Alliance
Susan Manber
Chief Patient Officer,
Publicis Health
Grace Cordovano, PhD, BCPA
Founder, Enlightening Results
Suzanne Garner
Director of Marketing & Community, Outcomes4Me, Breast Cancer Survivor
Kyle Holen, MD
SVP Head of Development, Therapeutics and Oncology, Moderna